Terrance Johns

7PUBLICATIONS

63CO-AUTHORS

Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Metabolic medicineHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Oct 06, 2026

DHODH is the key target of the KDM4 inhibitor QC6352 in glioblastoma stem cells.

|Aug 05, 2026

Intermittent fasting rewires tissue-specific gene-transposable element regulatory networks.

|Apr 17, 2026

Uncovering shared and tissue-specific molecular adaptations to intermittent fasting in liver, brain, and muscle.

|Feb 05, 2025

Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179.

Yuchen Li, Chaemin Lim, Taylor Dismuke

|May 25, 2024

An Anti-VEGF-B Antibody Reduces Abnormal Tumor Vasculature and Enhances the Effects of Chemotherapy.

Peter W Janes, Adam C Parslow, Diana Cao

|Jan 21, 2021

Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma.

Raelene Endersby, Jacqueline Whitehouse, Allison Pribnow

Pageof 2

Frequent Collaborators

Thiruma V Arumugam

Nishat I Tabassum

Lauren T Kerr

Peter W Janes

Adam C Parslow

Glenn A Cartwright

Ingrid J G Burvenich

Yuchen Li

Nicholas G Gottardo

Sho Oasa

Frequent Collaborators

Thiruma V Arumugam

Nishat I Tabassum

Lauren T Kerr

Peter W Janes